Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in Brazil

A Phase 3, Randomized, Active-Controlled, Double-Blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With Routine Pediatric Vaccinations in Brazil

The purpose of this study will be to analyze 13-valent pneumococcal vaccine given to healthy infants in Brazil for safety and tolerability, and to determine the immune response to the vaccines.

Inclusion criteria:

• Healthy 1 month old infants
• Available for the duration of the study and reachable by telephone
• Able to complete two blood drawing procedures during the study

Exclusion criteria:

• Previous vaccination, contraindication or history of allergic reaction to vaccine or vaccine components
• Bleeding disorder, immune deficiency or significant chronic or congenital disease
• Previous receipt of blood products or immune globulin